BetterMe Rx vs Midi Health
One of these is a rung on a published ladder with a milligram printed beside it; the other is a sale price that moves when the sitewide sale does.
BetterMe Rx
Editorial
$265/mo
The compounded semaglutide injection is $199 a month, under a struck-through anchor and a countdown that carries no end date and restarts every three days. Medication, provider review, compounding, supplies and shipping are stated to be included, and no membership is charged.
- Medication, provider review, supplies and shipping are stated to be included
- No membership or program fee sits outside the plan price
- Both molecules are offered as a tablet as well as an injection
- The plan length behind each low figure is printed on the card
- The countdown framing the intro price restarts on a three-day loop
- The struck-through reference price does not establish the charge for a selected plan
- The $99 headline requires a twelve-month commitment
- The compounding pharmacy is not named
Pick it for: A tablet, if the sale framing does not sway you
Not for: Anyone relying on a countdown without checking the actual plan terms.
Midi Health
Editorial
$226/mo
Every table on Midi's pricing page is labeled "4-week supply", so the $165.90 injectable floor is $180 a calendar month and the $164.00 sublingual floor is $178. Shipping and supplies sit inside those figures and no membership fee is charged, so the term is what a buyer has to convert.
- Every dose on four ladders carries its own published price
- Shipping and supplies sit inside the medication price
- No membership fee is charged beside the medication cost
- The 4-week term is printed above each table rather than buried
- Prices buy 4 weeks, so a calendar year costs thirteen fills
- The pricing page names a drug class and never the molecule
- Compounding pharmacies are described but not named
- Brand-name GLP-1 prescriptions carry no published price
Pick it for: Knowing what each milligram costs before the first fill
Not for: Anyone who needs the molecule and the pharmacy named before ordering.
Our verdict
Midi's tirzepatide figure buys a 4-week supply at 1 mg, and the sublingual ladder it sits at the bottom of reaches $460 at 7 mg — so the rung you settle on decides the year, not the entry. BetterMe Rx publishes no dose at all, and its tablet figure moves with a sitewide sale: it has already fallen $34 while the same seller's oral semaglutide rose $51.
What actually separates them
BetterMe Rx and Midi Health differ on published price, states a milligram dose and names its pharmacy. The table summarizes those terms; confirm any details it does not cover with the provider.
BetterMe Rx’s comparison figure is $39 higher than Midi Health’s — a 17% difference between the listed rates. These figures do not establish equivalent prescribed doses, supply or care. Confirm the selected product, full payment obligation and next charge.
At unchanged rates, a twelve-month illustration is about $2,712 at Midi Health against $3,180 at BetterMe Rx — a difference of $468. This is not a quote for a year of care: actual charges depend on prescribed supply, purchase terms and renewals.
| BetterMe Rx | Midi Health | |
|---|---|---|
| Published price | $265/mo | $226/mo |
| States a milligram dose | No | Yes |
| Names its pharmacy | No | Yes |
Before you choose either
Only one of these two publishes a milligram dose, which makes a straight price comparison impossible: you can tell what each costs, but only one tells you what you get. Ask the other what dose its price buys before you commit, then set both numbers against every published price we hold. A seller that will not answer that question has told you something.
Our take is computed from a published rubric that does not read commercial status, and what is known about safety applies to both of them equally.